Clinical Trial Update: Metastatic Leiomyosarcoma Biomarker Protocol

View source ↗

Summary

This clinical trial update describes a biomarker-driven protocol for metastatic leiomyosarcoma being conducted by the University of Michigan Rogel Cancer Center…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Leiomyosarcoma | Status: RECRUITING